![Leon J de Windt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leon J de Windt
Fondatore presso Mirabilis Therapeutics BV
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Jan Wit | M | - |
Mirabilis Therapeutics BV
![]() Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Mirabilis Therapeutics BV develops microRNA medicines. The Dutch company was founded in 2015 by Leon J de Windt, Jan Wit, and Paula A. Da Costa Martins. Jan Wit has been the CEO since 2015. | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Sjef de Kimpe | M | - |
University of Utrecht
| 10 anni |
Gerardus Cornelis M. W. Embrechts | M | 54 |
Maastricht University
| 7 anni |
Ingrid M. A. de Graaf-de Swart | M | 55 |
University of Utrecht
| 6 anni |
Sebastian Gröblinghoff | M | 45 |
Maastricht University
| 5 anni |
Geofrey de Visscher | M | - |
Maastricht University
| 3 anni |
Valentina Pippolo | F | - |
Maastricht University
| 4 anni |
Jan Bongaerts | M | 58 |
Maastricht University
| 2 anni |
Bas Xue | M | - |
University of Utrecht
| 4 anni |
Angelien G. Z. Kemna | M | 66 |
Maastricht University
| 6 anni |
Yvo Timmermans | M | - |
Maastricht University
| 6 anni |
Coenraad Johannes Weddepohl | M | - |
Maastricht University
| 4 anni |
Mirjam 't Lam | F | - |
Maastricht University
| 5 anni |
Hubertus J. M. Vrijhoef | M | - |
Maastricht University
| 3 anni |
Marc Rasmussen | M | - |
Maastricht University
| 7 anni |
Susan Gustafsson | F | 51 |
Maastricht University
| 1 anni |
Robin Schaede | M | 49 |
Maastricht University
| 5 anni |
Carolien Reijnen | F | - |
Maastricht University
| 5 anni |
Zhong Xi Cai | M | 59 |
Maastricht University
| 2 anni |
Xing Gang Qi | M | 51 |
Maastricht University
| 1 anni |
Steven ten Have | M | 56 |
University of Utrecht
| 3 anni |
Robbert Kessels | M | 49 |
Maastricht University
| 1 anni |
Fan Jianxiong | M | - |
Maastricht University
| 2 anni |
Caroline Princen | F | 57 |
University of Utrecht
| 4 anni |
Leon J. Schurgers | M | - |
Maastricht University
| 3 anni |
Ad W. van Gorp | M | - |
University of Utrecht
| 1 anni |
Pieter Doevendans | M | - |
Maastricht University
| 3 anni |
Nikolai R. D. Pronk | M | 50 |
Maastricht University
| 5 anni |
André van Puijenbroek | M | - |
University of Utrecht
| 1 anni |
Min Jie Xu | M | 65 |
Maastricht University
| 2 anni |
Ruud Wilders | M | - |
Maastricht University
| 10 anni |
Renée LeMaire | F | - |
Maastricht University
| 3 anni |
Marc van Dijk | M | 61 |
University of Utrecht
| 3 anni |
Peter Schrijnemaekers | M | 57 |
Maastricht University
| 7 anni |
Peter Wijngaard | M | 61 |
University of Utrecht
| 2 anni |
Ingo Jeroen Uytdehaage | M | 51 |
Maastricht University
| 2 anni |
Paula A. Da Costa Martins | F | - |
Mirabilis Therapeutics BV
![]() Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Mirabilis Therapeutics BV develops microRNA medicines. The Dutch company was founded in 2015 by Leon J de Windt, Jan Wit, and Paula A. Da Costa Martins. Jan Wit has been the CEO since 2015. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Paesi Bassi | 37 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Leon J de Windt
- Contatti personali